SciClone Raising Capital (SCLN)
SciClone Pharmaceuticals Inc. (NASDAQ: SCLN) has filed to raise capital, some for the company and some for its existing shareholders. The filing with the SEC includes the sale of any ...Read Full Story »
Posts related to ‘SciClone capital raise’
Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9948)
- Accounting (512)
- Active Trader (4408)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5079)
- Autos (1473)
- Banking & Finance (3794)
- Bankruptcy (282)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1997)
- Dividends & Buybacks (928)
- Earnings (4150)
- Economy (3702)
- Editor's Picks (516)
- ETFs & Mutual Funds (823)
- General (3838)
- Healthcare (1434)
- Housing (1039)
- Industrials (632)
- Infrastructure (605)
- International Markets (4174)
- Internet (2195)
- IPOs & Secondaries (1653)
- Jobs (158)
- Labor (656)
- Media (4204)
- Mergers & Acquisitions (2227)
- Oil & Gas (2576)
- Personal Finance (306)
- Politics (824)
- Polls (34)
- Regulation (1164)
- Retail (2584)
- Rumors (1093)
- Services (298)
- Special Report (376)
- Technology (3828)
- Telecom & Wireless (1693)
- Transportation (581)
- Value Investing (764)
